FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4293254658> ?p ?o ?g. }

• W4293254658 abstract "To investigate the association of concurrent use of oral anticoagulants (OACs) and sulfonylureas and the risk of hypoglycemia in individuals with type 2 diabetes mellitus (T2DM).A retrospective cohort study was conducted between 2001 and 2017 using electronic primary healthcare data from the IQVIA Medical Research Data (IMRD) that incorporates data supplied by The Health Improvement Network (THIN), a propriety database of Cegedim SA. Individuals with T2DM who received OAC prescription and sulfonylureas were included. We compared the risk of hypoglycemia with sulfonylureas and OACs using propensity score matching and Cox regression.109,040 individuals using warfarin and sulfonylureas and 77,296 using direct oral anticoagulants (DOACs) and sulfonylureas were identified and included. There were 285 hypoglycemia events in the warfarin with sulfonylureas group (incidence rate = 17.8 per 1,000 person-years), while in the sulfonylureas only, 304 hypoglycemia events were observed (incidence rate = 14.4 per 1,000 person-years). There were 14 hypoglycemic events in the DOACs with sulfonylureas group (incidence rates = 14.8 per 1,000 person-years), while in the sulfonylureas alone group, 60 hypoglycemia events were observed (incidence rate =23.7 per 1,000 person-years). Concurrent use of warfarin and sulfonylureas was associated with increased risk of hypoglycemia compared with sulfonylureas alone (HR 1.38; 95% CI 1.10-1.75). However, we found no evidence of an association between concurrent use of DOACs and sulfonylureas and risk of hypoglycemia (HR 0.54; 95% CI, 0.27-1.10) when compared with sulfonylureas only.We provide real-world evidence of possible drug-drug interactions between warfarin and sulfonylureas. The decision to prescribe warfarin with coexistent sulfonylureas to individuals with T2DM should be carefully evaluated in the context of other risk factors of hypoglycemia, and availability of alternative medications." @default.
• W4293254658 created "2022-08-27" @default.
• W4293254658 creator A5013042075 @default.
• W4293254658 creator A5029330906 @default.
• W4293254658 creator A5033259606 @default.
• W4293254658 creator A5048848026 @default.
• W4293254658 creator A5053772815 @default.
• W4293254658 creator A5072175850 @default.
• W4293254658 creator A5074194958 @default.
• W4293254658 creator A5089979499 @default.
• W4293254658 date "2022-08-23" @default.
• W4293254658 modified "2023-10-01" @default.
• W4293254658 title "Concurrent Use of Oral Anticoagulants and Sulfonylureas in Individuals With Type 2 Diabetes and Risk of Hypoglycemia: A UK Population-Based Cohort Study" @default.
• W4293254658 cites W104021497 @default.
• W4293254658 cites W1783190234 @default.
• W4293254658 cites W1964277517 @default.
• W4293254658 cites W1979698089 @default.
• W4293254658 cites W1988580567 @default.
• W4293254658 cites W1998425265 @default.
• W4293254658 cites W2006705572 @default.
• W4293254658 cites W2007006833 @default.
• W4293254658 cites W2009480581 @default.
• W4293254658 cites W2022425171 @default.
• W4293254658 cites W2025168202 @default.
• W4293254658 cites W2036193982 @default.
• W4293254658 cites W2056108924 @default.
• W4293254658 cites W2060316606 @default.
• W4293254658 cites W2060546728 @default.
• W4293254658 cites W2077641110 @default.
• W4293254658 cites W2087293229 @default.
• W4293254658 cites W2087587683 @default.
• W4293254658 cites W2087826156 @default.
• W4293254658 cites W2097854437 @default.
• W4293254658 cites W2098364806 @default.
• W4293254658 cites W2110818436 @default.
• W4293254658 cites W2111947972 @default.
• W4293254658 cites W2118114780 @default.
• W4293254658 cites W2126049444 @default.
• W4293254658 cites W2155718802 @default.
• W4293254658 cites W2161743657 @default.
• W4293254658 cites W2162508946 @default.
• W4293254658 cites W2176553054 @default.
• W4293254658 cites W2187626044 @default.
• W4293254658 cites W2321776862 @default.
• W4293254658 cites W2330467346 @default.
• W4293254658 cites W2464070018 @default.
• W4293254658 cites W2467976744 @default.
• W4293254658 cites W2598097718 @default.
• W4293254658 cites W2607507174 @default.
• W4293254658 cites W2756959803 @default.
• W4293254658 cites W2805684986 @default.
• W4293254658 cites W2996828644 @default.
• W4293254658 cites W2999886187 @default.
• W4293254658 cites W3024500389 @default.
• W4293254658 cites W3045009783 @default.
• W4293254658 cites W3121321954 @default.
• W4293254658 cites W3177217938 @default.
• W4293254658 doi "https://doi.org/10.3389/fmed.2022.893080" @default.
• W4293254658 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36082271" @default.
• W4293254658 hasPublicationYear "2022" @default.
• W4293254658 type Work @default.
• W4293254658 citedByCount "1" @default.
• W4293254658 countsByYear W42932546582023 @default.
• W4293254658 crossrefType "journal-article" @default.
• W4293254658 hasAuthorship W4293254658A5013042075 @default.
• W4293254658 hasAuthorship W4293254658A5029330906 @default.
• W4293254658 hasAuthorship W4293254658A5033259606 @default.
• W4293254658 hasAuthorship W4293254658A5048848026 @default.
• W4293254658 hasAuthorship W4293254658A5053772815 @default.
• W4293254658 hasAuthorship W4293254658A5072175850 @default.
• W4293254658 hasAuthorship W4293254658A5074194958 @default.
• W4293254658 hasAuthorship W4293254658A5089979499 @default.
• W4293254658 hasBestOaLocation W42932546581 @default.
• W4293254658 hasConcept C120665830 @default.
• W4293254658 hasConcept C121332964 @default.
• W4293254658 hasConcept C126322002 @default.
• W4293254658 hasConcept C134018914 @default.
• W4293254658 hasConcept C167135981 @default.
• W4293254658 hasConcept C2776301958 @default.
• W4293254658 hasConcept C2777180221 @default.
• W4293254658 hasConcept C2779161974 @default.
• W4293254658 hasConcept C2779306644 @default.
• W4293254658 hasConcept C2780668416 @default.
• W4293254658 hasConcept C2908647359 @default.
• W4293254658 hasConcept C555293320 @default.
• W4293254658 hasConcept C61511704 @default.
• W4293254658 hasConcept C71924100 @default.
• W4293254658 hasConcept C99454951 @default.
• W4293254658 hasConceptScore W4293254658C120665830 @default.
• W4293254658 hasConceptScore W4293254658C121332964 @default.
• W4293254658 hasConceptScore W4293254658C126322002 @default.
• W4293254658 hasConceptScore W4293254658C134018914 @default.
• W4293254658 hasConceptScore W4293254658C167135981 @default.
• W4293254658 hasConceptScore W4293254658C2776301958 @default.
• W4293254658 hasConceptScore W4293254658C2777180221 @default.
• W4293254658 hasConceptScore W4293254658C2779161974 @default.
• W4293254658 hasConceptScore W4293254658C2779306644 @default.
• W4293254658 hasConceptScore W4293254658C2780668416 @default.
• W4293254658 hasConceptScore W4293254658C2908647359 @default.
• W4293254658 hasConceptScore W4293254658C555293320 @default.

• next